Quintiles and Quest Diagnostics combine to deliver Q2 Solutions, highlighting biopharma’s need for patient data in the era of precision medicine. This is exactly why Novaseek developed the platform to make clinical data and biospecimens readily available to the industry and that would be an important complement to services provided by CROs and Clinical labs.
Foundation Medicine and IMS Health recently announced a collaboration to leverage IMS’s Real-World Evidence platform and Foundation Medicine’s knowledgebase of comprehensive cancer genomic profiles to improve cancer care by better connecting patients to the right targeted therapies at the right time. Once valuable insights are generated, platforms like Novaseek will help to put the actionable data at the fingertips of community oncologists.
More efforts are underway to bring relevant patient data into research. The Reagan-Udall Foundation’s Big Data for Patients (BD4P) initiative will make clinical patient data more relatable and less intimidating for patients, while ensuring that patients are better equipped to actively engage in precision medicine research and healthcare.
The need and demand in research for large clinical patient datasets is powerful, as seen by “Apple ResearchKit” new mobile platform. Our Novaseek platform is also addressing this demand by enabling hospitals and patients to provide biospecimens and clinical data for research without deviating from established hospital workflows in patient care. “The incentive is to bring many more thousands of participants to human research. And with greater numbers of participants will come greater power to the results,” and we could not agree more.